183 related articles for article (PubMed ID: 27130863)
1. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
Hsu AP; West RR; Calvo KR; Cuellar-Rodriguez J; Parta M; Kelly SJ; Ganson NJ; Hershfield MS; Holland SM; Hickstein DD
J Allergy Clin Immunol; 2016 Aug; 138(2):628-630.e2. PubMed ID: 27130863
[No Abstract] [Full Text] [Related]
2. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
[No Abstract] [Full Text] [Related]
3. [Treatment of deficiency of adenosine deaminase 2 caused by CECR1 mutation with myeloablative hematopoietic stem cell transplantation].
Song XC; Zhou F
Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):509-511. PubMed ID: 32521966
[TBL] [Abstract][Full Text] [Related]
4. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.
Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442
[No Abstract] [Full Text] [Related]
5. Homozygous Splice ADA2 Gene Mutation Causing ADA-2 Deficiency.
Chong-Neto HJ; Segundo GRS; Bandeira M; Chong-Silva DC; Rosário CS; Riedi CA; Hershfield MS; Ochs H; Torgerson T; Rosário NA
J Clin Immunol; 2019 Nov; 39(8):842-845. PubMed ID: 31617030
[No Abstract] [Full Text] [Related]
6. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
[TBL] [Abstract][Full Text] [Related]
7. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.
Lee PY; Huang Y; Zhou Q; Schnappauf O; Hershfield MS; Li Y; Ganson NJ; Sampaio Moura N; Delmonte OM; Stone SS; Rivkin MJ; Pai SY; Lyons T; Sundel RP; Hsu VW; Notarangelo LD; Aksentijevich I; Nigrovic PA
J Allergy Clin Immunol; 2018 Oct; 142(4):1363-1365.e8. PubMed ID: 29936104
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey.
Kisla Ekinci RM; Balci S; Hershfield M; Bisgin A; Dogruel D; Altintas DU; Yilmaz M
Rheumatology (Oxford); 2020 Jan; 59(1):254-256. PubMed ID: 31292637
[No Abstract] [Full Text] [Related]
9. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
10. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).
Brooks JP; Rice AJ; Ji W; Lanahan SM; Konstantino M; Dara J; Hershfield MS; Cruickshank A; Dokmeci E; Lakhani S; Lucas CL
J Clin Immunol; 2021 Apr; 41(3):680-683. PubMed ID: 33394316
[No Abstract] [Full Text] [Related]
11. [Adenosine deaminase 2 deficiency: a disease with multiple presentations].
Caratsch L; Schnider C; Moi L; Theodoropoulou K; Candotti F; Hofer M
Rev Med Suisse; 2022 Apr; 18(776):669-673. PubMed ID: 35385618
[TBL] [Abstract][Full Text] [Related]
12. ADA2 deficiency due to a novel structural variation in 22q11.1.
Grossi A; Cusano R; Rusmini M; Penco F; Schena F; Podda RA; Caorsi R; Gattorno M; Uva P; Ceccherini I
Clin Genet; 2019 Jun; 95(6):732-733. PubMed ID: 30920658
[No Abstract] [Full Text] [Related]
13. Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency.
Insalaco A; Moneta GM; Pardeo M; Caiello I; Messia V; Bracaglia C; Passarelli C; De Benedetti F
J Rheumatol; 2019 May; 46(5):523-526. PubMed ID: 30647181
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for ADA-SCID, the first marketing approval of an
Aiuti A; Roncarolo MG; Naldini L
EMBO Mol Med; 2017 Jun; 9(6):737-740. PubMed ID: 28396566
[TBL] [Abstract][Full Text] [Related]
15. A Chinese DADA2 patient: report of two novel mutations and successful HSCT.
Liu L; Wang W; Wang Y; Hou J; Ying W; Hui X; Zhou Q; Liu D; Yao H; Sun J; Wang X
Immunogenetics; 2019 Apr; 71(4):299-305. PubMed ID: 30610243
[TBL] [Abstract][Full Text] [Related]
16. Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient.
Lanfranchi A; Lougaris V; Notarangelo LD; Soncini E; Comini M; Beghin A; Bolda F; Montanelli A; Imberti L; Porta F
Clin Immunol; 2018 Aug; 193():118-120. PubMed ID: 29355610
[TBL] [Abstract][Full Text] [Related]
17. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase deficiency: a review.
Flinn AM; Gennery AR
Orphanet J Rare Dis; 2018 Apr; 13(1):65. PubMed ID: 29690908
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2.
Keino D; Kondoh K; Kim Y; Sudo A; Ohyama R; Morimoto M; Nihira H; Izawa K; Iwaki-Egawa S; Mori T; Kinoshita A
Scand J Rheumatol; 2021 May; 50(3):243-245. PubMed ID: 32720851
[No Abstract] [Full Text] [Related]
20. Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
Poswar Fde O; da Fonseca RM; de Albuquerque LC; Zhou Q; Jardim LB; Monte TL; Aksentijevich I; Saute JA
J Neurol; 2016 Apr; 263(4):818-20. PubMed ID: 26914925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
